Interleukin‐15 in combination with T‐cell immunoglobulin and immunoreceptor tyrosine‐based inhibitory motif domain blockade enhances the activation and cytotoxicity of CD8+ tumour‐infiltrating lymphocytes in lung adenocarcinoma. The gene discussed is CD8A; the disease is neoplasm.